Cargando…
Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women
BACKGROUND: Glucocorticoids could theoretically decrease breast cancer risk through their anti-inflammatory effects or increase risk through immunosuppression. However, epidemiological evidence is limited regarding the associations between glucocorticoid use and breast cancer risk. METHODS: We inves...
Autores principales: | Cairat, Manon, Al Rahmoun, Marie, Gunter, Marc J., Heudel, Pierre-Etienne, Severi, Gianluca, Dossus, Laure, Fournier, Agnès |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330083/ https://www.ncbi.nlm.nih.gov/pubmed/34340701 http://dx.doi.org/10.1186/s12916-021-02004-6 |
Ejemplares similares
-
Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women
por: Cairat, Manon, et al.
Publicado: (2020) -
Antiplatelet drugs and breast cancer risk in a large nationwide Danish case‐control study
por: Cairat, Manon, et al.
Publicado: (2022) -
Colorectal cancer risk following appendectomy: a pooled analysis of three large prospective cohort studies
por: Rothwell, Joseph A., et al.
Publicado: (2022) -
Association between Melanocytic Nevi and Risk of Breast Diseases: The French E3N Prospective Cohort
por: Kvaskoff, Marina, et al.
Publicado: (2014) -
Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis
por: Mori, Nagisa, et al.
Publicado: (2021)